Growth Metrics

Cellectis (CLLS) EBT Margin (QoQ) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Cellectis 20.83 Bn 20.62 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 49,119.00
Dec 31, 2025 -90,379.00
Sep 30, 2025 -656.00
Jun 30, 2025 9,735.00
Mar 31, 2025 23,890.00
Dec 31, 2024 -30,445.00
Sep 30, 2024 3,564.00
Jun 30, 2024 38,517.00
Mar 31, 2024 3.07 Mn
Dec 31, 2023 -2.20 Mn
Sep 30, 2023 -1.09 Mn
Jun 30, 2023 1.49 Mn
Mar 31, 2023 -1.31 Mn
Dec 31, 2022 1.50 Mn
Sep 30, 2022 -1.30 Mn
Jun 30, 2022 -28,649.00
Mar 31, 2022 -159,520.00
Dec 31, 2021 43,105.00
Sep 30, 2021 -17,435.00
Jun 30, 2021 -25,761.00
Mar 31, 2021 20,918.00
Dec 31, 2020 18,811.00
Sep 30, 2020 66,396.00
Jun 30, 2020 -116,775.00
Mar 31, 2020 89,909.00
Dec 31, 2019 -55,632.00
Sep 30, 2019 273,511.00
Jun 30, 2019 -81,757.00
Mar 31, 2019 79,168.00
Dec 31, 2018 16,704.00
Sep 30, 2018 -276,058.00
Jun 30, 2018 -1,742.00
Mar 31, 2018 -1,052.00
Dec 31, 2017 1,808.00
Sep 30, 2017 -11,440.00
Jun 30, 2017 -1,220.00
Mar 31, 2017 -4,538.00
Dec 31, 2016 -13,339.00
Sep 30, 2016 156,358.00
Jun 30, 2016 -138,558.00
Mar 31, 2016 -29,613.00
Dec 31, 2015 18,059.00
Sep 30, 2015 -1,146.00
Jun 30, 2015 -12,326.00